T&R Biofab Co., Ltd. (KOSDAQ:246710)

South Korea · Delayed Price · Currency is KRW

1,701.00

-56.00 (-3.19%)

Nov 3, 2026, 3:19 PM KST

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Biomedical Engineering Devices Division	7.58B	4.87B	5.20B
Cosmetics and Container Division	19.54B	-	-
Inter-Segmental Revenue	-148.42M	-	-
Total	26.97B	4.87B	5.20B

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
South Korea	24.12B	4.33B	4.61B
USA	1.21B	25.06M	150.17K
Philippines	127.94M	162.75M	82.51M
Malaysia	114.19M	-	-
Mongolia	1.23M	-	-
Japan	22.17M	30.74M	18.10M
China	630.25M	-	-
Hong Kong	346.32M	-	-
Australia	205.42M	-	-
Taiwan	18.90M	12.82M	20.35M
Europe	48.69M	14.50M	1.15M
Colombia	2.76M	-	-
Vietnam	100.71M	298.06M	462.15M
Thailand	15.98M	-	-
Indonesia	3.07M	-	-
Mexico	155.31K	-	-
Total	26.97B	4.87B	5.20B